126 related articles for article (PubMed ID: 15497209)
1. Products containing bitter orange or synephrine: suspected cardiovascular adverse reactions.
Jordan S; Murty M; Pilon K
CMAJ; 2004 Oct; 171(8):993-4. PubMed ID: 15497209
[No Abstract] [Full Text] [Related]
2. Synephrine: from trace concentrations to massive consumption in weight-loss.
Stohs SJ
Food Chem Toxicol; 2011 Jun; 49(6):1472-3; author reply 1474-5. PubMed ID: 21439342
[No Abstract] [Full Text] [Related]
3. The safety of Citrus aurantium (bitter orange) and its primary protoalkaloid p-synephrine.
Stohs SJ; Preuss HG; Shara M
Phytother Res; 2011 Oct; 25(10):1421-8. PubMed ID: 21480414
[TBL] [Abstract][Full Text] [Related]
4. Possible association of acute lateral-wall myocardial infarction and bitter orange supplement.
Nykamp DL; Fackih MN; Compton AL
Ann Pharmacother; 2004 May; 38(5):812-6. PubMed ID: 15026566
[TBL] [Abstract][Full Text] [Related]
5. "Ephedra-free" diet pill-induced psychosis.
Retamero C; Rivera T; Murphy K
Psychosomatics; 2011; 52(6):579-82. PubMed ID: 22054631
[No Abstract] [Full Text] [Related]
6. [Risk assessment of synephrine in dietary supplements].
Bakhyia N; Dusemund B; Richter K; Lindtner O; Hirsch-Ernst KI; Schäfer B; Lampen A
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Mar; 60(3):323-331. PubMed ID: 28058460
[TBL] [Abstract][Full Text] [Related]
7. Bitter orange weight loss products may not be safe.
Health News; 2004 Dec; 10(12):9. PubMed ID: 15645567
[No Abstract] [Full Text] [Related]
8. Unsupported conclusions in the article "Synephrine-containing dietary supplement precipitating apical ballooning syndrome in a young female".
Stohs SJ
Korean J Intern Med; 2014 May; 29(3):388-92. PubMed ID: 24851076
[No Abstract] [Full Text] [Related]
9. Mass spectrometric determination of the predominant adrenergic protoalkaloids in bitter orange (Citrus aurantium).
Nelson BC; Putzbach K; Sharpless KE; Sander LC
J Agric Food Chem; 2007 Nov; 55(24):9769-75. PubMed ID: 17966980
[TBL] [Abstract][Full Text] [Related]
10. Determination of synephrine in weight-loss products using high performance liquid chromatography with acidic potassium permanganate chemiluminescence detection.
Slezak T; Francis PS; Anastos N; Barnett NW
Anal Chim Acta; 2007 Jun; 593(1):98-102. PubMed ID: 17531829
[TBL] [Abstract][Full Text] [Related]
11. A rapid liquid chromatography electrospray ionization mass spectrometry(n) method for evaluation of synephrine in Citrus aurantium L. samples.
Mattoli L; Cangi F; Maidecchi A; Ghiara C; Tubaro M; Traldi P
J Agric Food Chem; 2005 Dec; 53(26):9860-6. PubMed ID: 16366666
[TBL] [Abstract][Full Text] [Related]
12. Citrus aurantium--beware of the bitter orange.
Louw VJ; Louw H
S Afr Med J; 2008 Jul; 98(7):496. PubMed ID: 18785379
[No Abstract] [Full Text] [Related]
13. Review of Published Bitter Orange Extract and
Stohs SJ; Ray SD
J Diet Suppl; 2020; 17(3):355-363. PubMed ID: 30835576
[No Abstract] [Full Text] [Related]
14. Exactly which synephrine alkaloids does Citrus aurantium (bitter orange) contain?
Allison DB; Cutter G; Poehlman ET; Moore DR; Barnes S
Int J Obes (Lond); 2005 Apr; 29(4):443-6. PubMed ID: 15700046
[TBL] [Abstract][Full Text] [Related]
15. [Synephrine in dietary supplements and specialized foodstuffs: biological activity, safety and methods of analysis].
Perova IB; Eller KI; Musatov AV; Tymolskaya EV
Vopr Pitan; 2021; 90(6):101-113. PubMed ID: 35032130
[TBL] [Abstract][Full Text] [Related]
16. Absence of QTc-interval-prolonging or hemodynamic effects of a single dose of bitter-orange extract in healthy subjects.
Min B; Cios D; Kluger J; White CM
Pharmacotherapy; 2005 Dec; 25(12):1719-24. PubMed ID: 16305290
[TBL] [Abstract][Full Text] [Related]
17. Synephrine is not Neo-Synephrine.
Bouchard N; Hoffman RS
Mayo Clin Proc; 2004 Dec; 79(12):1589-90; author reply 1590; discussion 1590. PubMed ID: 15595351
[No Abstract] [Full Text] [Related]
18. STEMI in a 24-year-old man after use of a synephrine-containing dietary supplement: a case report and review of the literature.
Thomas JE; Munir JA; McIntyre PZ; Ferguson MA
Tex Heart Inst J; 2009; 36(6):586-90. PubMed ID: 20069086
[TBL] [Abstract][Full Text] [Related]
19. A review of the human clinical studies involving Citrus aurantium (bitter orange) extract and its primary protoalkaloid p-synephrine.
Stohs SJ; Preuss HG; Shara M
Int J Med Sci; 2012; 9(7):527-38. PubMed ID: 22991491
[TBL] [Abstract][Full Text] [Related]
20. Chromatographic and electrophoretic methods for the analysis of phenethylamine [corrected] alkaloids in Citrus aurantium.
Pellati F; Benvenuti S
J Chromatogr A; 2007 Aug; 1161(1-2):71-88. PubMed ID: 17582424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
